55 related articles for article (PubMed ID: 26060100)
1. Expression of RUNX1-ETO Rapidly Alters the Chromatin Landscape and Growth of Early Human Myeloid Precursor Cells.
Nafria M; Keane P; Ng ES; Stanley EG; Elefanty AG; Bonifer C
Cell Rep; 2020 May; 31(8):107691. PubMed ID: 32460028
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Runx1 chromatin boundaries affect gene expression in hematopoietic development.
Owens DDG; Anselmi G; Oudelaar AM; Downes DJ; Cavallo A; Harman JR; Schwessinger R; Bucakci A; Greder L; de Ornellas S; Jeziorska D; Telenius J; Hughes JR; de Bruijn MFTR
Nat Commun; 2022 Feb; 13(1):773. PubMed ID: 35140205
[TBL] [Abstract][Full Text] [Related]
3. Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
Dagoneau N; Scheffer D; Huber C; Al-Gazali LI; Di Rocco M; Godard A; Martinovic J; Raas-Rothschild A; Sigaudy S; Unger S; Nicole S; Fontaine B; Taupin JL; Moreau JF; Superti-Furga A; Le Merrer M; Bonaventure J; Munnich A; Legeai-Mallet L; Cormier-Daire V
Am J Hum Genet; 2004 Feb; 74(2):298-305. PubMed ID: 14740318
[TBL] [Abstract][Full Text] [Related]
4. RUNX1 is required in granulocyte-monocyte progenitors to attenuate inflammatory cytokine production by neutrophils.
Zezulin AU; Yen D; Ye D; Howell ED; Bresciani E; Diemer J; Ren JG; Ahmad MH; Castilla LH; Touw IP; Minn AJ; Tong W; Liu PP; Tan K; Yu W; Speck NA
Genes Dev; 2023 Jul; 37(13-14):605-620. PubMed ID: 37536952
[TBL] [Abstract][Full Text] [Related]
5. Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia.
Aoki K; Hyuga M; Tarumoto Y; Nishibuchi G; Ueda A; Ochi Y; Sugino S; Mikami T; Kobushi H; Kato I; Akahane K; Inukai T; Takaori-Kondo A; Takita J; Ogawa S; Yusa K
Blood; 2024 Feb; 143(7):604-618. PubMed ID: 37922452
[TBL] [Abstract][Full Text] [Related]
6. RUNX1 regulates promoter activity in the absence of cognate DNA binding motifs.
Woodworth AM; Hardy K; Taberlay PC; Dickinson JL; Holloway AF
J Cell Biochem; 2024 Apr; ():. PubMed ID: 38616697
[TBL] [Abstract][Full Text] [Related]
7. Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid Leukemia.
Klco J; Thomas M; Qi W; Walsh M; Ma J; Westover T; Abdelhamed S; Ezzell L; Rolle C; Xiong E; Rosikiewicz W; Xu B; Pruett-Miller S; Loughran A; Janke L
Res Sq; 2023 Sep; ():. PubMed ID: 37790524
[TBL] [Abstract][Full Text] [Related]
8. LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer.
Tang W; Ramasamy K; Pillai SMA; Santhamma B; Konda S; Pitta Venkata P; Blankenship L; Liu J; Liu Z; Altwegg KA; Ebrahimi B; Pratap UP; Li X; Valente PT; Kost E; Sareddy GR; Vadlamudi RK; Nair HB; Tekmal RR; Viswanadhapalli S
Cell Death Discov; 2021 Aug; 7(1):216. PubMed ID: 34400617
[TBL] [Abstract][Full Text] [Related]
9. RUNX1 C-terminal Mutations Impair Blood Cell Differentiation by Perturbing Specific Enhancer-Promoter Networks.
Jayne ND; Liang Z; Lim DH; Chen PB; Diaz C; Arimoto KI; Xia L; Liu M; Ren B; Fu XD; Zhang DE
Blood Adv; 2024 Mar; ():. PubMed ID: 38513139
[TBL] [Abstract][Full Text] [Related]
10. Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells.
Cai X; Gao L; Teng L; Ge J; Oo ZM; Kumar AR; Gilliland DG; Mason PJ; Tan K; Speck NA
Cell Stem Cell; 2015 Aug; 17(2):165-77. PubMed ID: 26165925
[TBL] [Abstract][Full Text] [Related]
11. Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.
Li H; Zhao X; Yan X; Jessen WJ; Kim MO; Dombi E; Liu PP; Huang G; Wu J
Oncogene; 2016 Mar; 35(11):1468-74. PubMed ID: 26073082
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis.
Janssens K; Slaets H; Hellings N
Ann N Y Acad Sci; 2015 Sep; 1351():52-60. PubMed ID: 26100315
[TBL] [Abstract][Full Text] [Related]
13. The Role of Breast Cancer Cells in Bone Metastasis: Suitable Seeds for Nourishing Soil.
Wang Y; Hu Y; Wang M; Wang M; Xu Y
Curr Osteoporos Rep; 2024 Feb; 22(1):28-43. PubMed ID: 38206556
[TBL] [Abstract][Full Text] [Related]
14. The Multiple Interactions of RUNX with the Hippo-YAP Pathway.
Chuang LSH; Ito Y
Cells; 2021 Oct; 10(11):. PubMed ID: 34831147
[TBL] [Abstract][Full Text] [Related]
15. Emerging Perspectives on Leukemia Inhibitory Factor and its Receptor in Cancer.
Christianson J; Oxford JT; Jorcyk CL
Front Oncol; 2021; 11():693724. PubMed ID: 34395259
[TBL] [Abstract][Full Text] [Related]
16. PAK4 phosphorylating RUNX1 promotes ERĪ±-positive breast cancer-induced osteolytic bone destruction.
Tang L; Gao Y; Song Y; Li Y; Li Y; Zhang H; Li D; Li J; Liu C; Li F
Int J Biol Sci; 2020; 16(12):2235-2247. PubMed ID: 32549768
[TBL] [Abstract][Full Text] [Related]
17. The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.
Qadi AA; Taberlay PC; Phillips JL; Young A; West AC; Brettingham-Moore KH; Dickinson JL; Holloway AF
J Cell Biochem; 2016 Jan; 117(1):49-58. PubMed ID: 26060100
[TBL] [Abstract][Full Text] [Related]
18. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
19. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells
Liu S; Xing Y; Lu W; Li S; Tian Z; Xing H; Tang K; Xu Y; Rao Q; Wang M; Wang J
Haematologica; 2019 Aug; 104(8):1597-1607. PubMed ID: 30792202
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
